(Date:9/5/2008)... Sept. 5 /PRNewswire/ -- EthicAd, a nonprofit orga...h consumer education, announces,the launch of a ne...better,understand direct-to-consumer (DTC) adverti...art About Prescription Drug Advertising," is,hoste...arch and was,developed by the FDA in partnership w...
(Date:9/5/2008)...risk is greatest for those overweight or obese at ...ws) -- Almost half of all American adults will dev...ir odds increase if they are obese in middle age, ...the painful condition increased as his or her body...y of North Carolina at Chapel Hill study. People w...
(Date:9/5/2008)...s say patients taking meds on Web site shouldn,t o... Sept. 5 (HealthDay News) -- The U.S. Food and Dru...te drugs being evaluated for potential safety issu...rs on a quarterly report, it means we have begun a...blem that requires further evaluation," Dr. Gerald...
(Date:9/5/2008)...Lung cancer risk prediction models are enhanced by...easuring DNA repair capacity, according to researc...f Texas M. D. Anderson Cancer Center in two comple... Cancer Prevention Research . , In the first st...nd unique results based on increased exposure to c...
Breaking Medicine News(10 mins):Health News:Prescription Drug Advertising Subject of New FDA Web Site for Consumers 2Health News:Almost Half of Adults Will Develop Knee Osteoarthritis by 85 2Health News:FDA to List Drugs Under Review for Safety Issues 2Health News:Creating lung cancer risk models for specific populations refines prediction 2Health News:Creating lung cancer risk models for specific populations refines prediction 3(Date:9/4/2008)...d Presented at ESC Congress-, PHILADELPHIA, Sept....l,study, the GISSI Heart Failure (GISSI-HF) study,...rs reduced all cause mortality and hospital,admiss...hronic heart,failure. These findings are published... were presented at the European Cardiovascular Soc...
(Date:9/4/2008)...limumab to be Presented, PRINCETON, N.J., Sept. 4... MEDX ) announced today that nine clinical abstrac...antibody, in melanoma are scheduled to be,the subj...uropean Society,for Medical Oncology (ESMO) being ...he following abstracts will include updated one-ye...
(Date:9/3/2008)...Children Studied. Wrong,Conclusions Reached., NIX...rs for Disease,Control and Prevention (CDC) study ... MMR vaccine and autism. The National Autism Assoc...l the growing public concern over a,vaccine-autism...g design,and methodology., For years, parents hav...
(Date:9/3/2008)... /- Artelis SA and,Selexis SA announc...ntibody,production with the achievement of manufac...ord level was accomplished by applying two highly,...able Selexis CHO,production cell line rapidly gene... using their proprietary Selexis Genetic Elements(...
Breaking Medicine Technology:New Data Shows Prescription Omega-3 Acid Ethyl Esters Reduced the Incidence of Death in Heart Failure Patients 2New Data Shows Prescription Omega-3 Acid Ethyl Esters Reduced the Incidence of Death in Heart Failure Patients 3New Data Shows Prescription Omega-3 Acid Ethyl Esters Reduced the Incidence of Death in Heart Failure Patients 4Medarex Announces Presentations at the 33rd Congress of the European Society for Medical Oncology 2Medarex Announces Presentations at the 33rd Congress of the European Society for Medical Oncology 3CDC Misses Target With Flawed MMR/Autism Study 2Artelis and Selexis Report Record Antibody Production Levels in CHO Cells of Over 31 Grams Per Liter 2Artelis and Selexis Report Record Antibody Production Levels in CHO Cells of Over 31 Grams Per Liter 3The Highmark Foundation Announces 241 Million School Challenge Program 6501 1The Highmark Foundation Announces 241 Million School Challenge Program 6501 2 245 M Gift Boosts Childhood Oral Health Care Offered by UW Childrens Hospital 6499 1 245 M Gift Boosts Childhood Oral Health Care Offered by UW Childrens Hospital 6499 2Neuromuscular Dentistry Ends Womans Migraines 6497 1Neuromuscular Dentistry Ends Womans Migraines 6497 2Bee strategy helps servers run more sweetly 1252 1Bee strategy helps servers run more sweetly 1252 2Bee strategy helps servers run more sweetly 1252 3...onstrate Meaningful Placebo Adjusted Weight,Loss; ... 09, 2007 /PRNewswire-FirstCall/ -- Manhattan,Phar...ompany,s two,Phase 2a clinical trials of oral Oleo...ouble-blind, placebo-controlled studies, one,in co...nstrated no,statistically or clinically meaningful...
...PH20 with Humira Estimated to Increase the,Maximal...% to 100%,-, SAN DIEGO, July 09, 2007 /PRNewswire-...harmaceutical company developing and,commercializi...,final results of the Enhanze(TM) Technology clini...oavailability of a,representative commercially-ava...
Other Medicine Technology:Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for,Oral Oleoyl-estrone 2Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for,Oral Oleoyl-estrone 3Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for,Oral Oleoyl-estrone 4Halozyme Therapeutics' Enhanze Technology Large Protein Molecule,Therapeutic Clinical Trial Results Presented at the 34th Annual,Meeting of the Controlled Release Society 2Halozyme Therapeutics' Enhanze Technology Large Protein Molecule,Therapeutic Clinical Trial Results Presented at the 34th Annual,Meeting of the Controlled Release Society 3Halozyme Therapeutics' Enhanze Technology Large Protein Molecule,Therapeutic Clinical Trial Results Presented at the 34th Annual,Meeting of the Controlled Release Society 4Halozyme Therapeutics' Enhanze Technology Large Protein Molecule,Therapeutic Clinical Trial Results Presented at the 34th Annual,Meeting of the Controlled Release Society 5Used for complex diagnostic and interventional procedures.
The Emerald Guidewire is intended for percutaneous introduction of catheters.
St. Jude Medical offers a complete line of diagnostic guidewires for use with percutaneous catheter introducers to aid the insertion of intravascular catheters. Our diagnostic guidewires are availabl
Used to negotiate tortuous vessels.
Medicine Products: